tirzepatide washout period 🧠Let's break the drug down using this mnemonic cloud!⁠ ⁠ 💉 Tirzepatide is a GLP-1 and GIP agonist. ⁠ ⁠ 🤔But what exactly is glucagon-like peptide (GLP-1) and gastric inhibitory polypeptide (GIP)? ⁠ ⁠ The Hidden Cost of GLP-1s:

If an unacceptable increase in cardiovascular risk was discharged at the interim analysis, close-out of the ongoing SURPASS-4 trial was to be initiated, with an anticipated close-out period of 3 months, during which accrual of additional MACE-4 was possible

Continuous monitoring and research aim to provide a more thorough understanding of the safety profile associated with Zepbound

The side effect comparison between semaglutide and tirzepatide also shows relevant differences

Regarding renal function, no dose adjustment is required for patients with renal impairment, including those with end-stage renal disease

The pivotal SURMOUNT and SURPASS trial programs primarily focused on weight loss and glycemic outcomes, with reproductive health not designated as a primary endpoint

Management options may include dose adjustment, temporary treatment interruption, addressing contributing factors (such as optimizing management of gastrointestinal side effects), or considering alternative weight management strategies if symptoms persist and significantly impact quality of life